Breast cancer is increasingly prevalent in older adults and is a substantial part of routine
oncology practice. However, management of breast cancer in this population is challenging …

In recent years, major advances have been made toward the individualization of epithelial
ovarian cancer care, leading to an overall improvement of patient outcomes. However, real …

Simple Summary Breast cancer emergencies have become a rapidly evolving field in
medicine during the last ten years. Carcinogenesis is a multiparametric process that …

Background Poly-(ADP-ribose)-polymerase (PARP) inhibitors have shown to be effective as
maintenance treatment in patients with advanced ovarian cancer. Although most ovarian …

Abstract Background The phase III PAOLA-1/ENGOT-ov25 study (NCT02477644) showed
that addition of olaparib to bevacizumab maintenance improved progression-free survival …

Age is one of the most important risk factors for the development of breast cancer. Nearly a
third of all breast cancer cases occur in older women (aged≥ 70 years), with most cases …

Simple Summary Fatigue in older patients has multiple etiologies, as this symptom may be
cancer-related, treatment-related, age-related, or part of frailty syndrome. Physicians need to …

Background In the phase 3 trial ARIEL3, maintenance treatment with the poly (ADP-ribose)
polymerase (PARP) inhibitor rucaparib provided clinical benefit versus placebo for patients …

As a result of aging of the population, the number of older patients with cancer is growing
worldwide. Optimal approach and treatment strategies for older cancer patients can …

Simple Summary This position paper aims to provide practitioners a proposal for
multidisciplinary care planning for older patients with ovarian cancer from the time of …